178 related articles for article (PubMed ID: 38442735)
1. The electrophysiologic effects of KCNQ1 extend beyond expression of IKs: evidence from genetic and pharmacologic block.
Wada Y; Wang L; Hall LD; Yang T; Short LL; Solus JF; Glazer AM; Roden DM
Cardiovasc Res; 2024 May; 120(7):735-744. PubMed ID: 38442735
[TBL] [Abstract][Full Text] [Related]
2. Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.
Zhang M; D'Aniello C; Verkerk AO; Wrobel E; Frank S; Ward-van Oostwaard D; Piccini I; Freund C; Rao J; Seebohm G; Atsma DE; Schulze-Bahr E; Mummery CL; Greber B; Bellin M
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5383-92. PubMed ID: 25453094
[TBL] [Abstract][Full Text] [Related]
3. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
Bodi I; Franke G; Pantulu ND; Wu K; Perez-Feliz S; Bode C; Zehender M; zur Hausen A; Brunner M; Odening KE
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1163-71. PubMed ID: 23718892
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Ma D; Wei H; Lu J; Huang D; Liu Z; Loh LJ; Islam O; Liew R; Shim W; Cook SA
Stem Cell Res Ther; 2015 Mar; 6(1):39. PubMed ID: 25889101
[TBL] [Abstract][Full Text] [Related]
6. Disease characterization using LQTS-specific induced pluripotent stem cells.
Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
[TBL] [Abstract][Full Text] [Related]
7. Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects.
Lin Y; Grinter SZ; Lu Z; Xu X; Wang HZ; Liang H; Hou P; Gao J; Clausen C; Shi J; Zhao W; Ma Z; Liu Y; White KM; Zhao L; Kang PW; Zhang G; Cohen IS; Zou X; Cui J
Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33990467
[TBL] [Abstract][Full Text] [Related]
8. Paroxysmal beta-adrenergic receptor-mediated alterations in ventricular repolarization at rapid heart rates during inhibition of delayed rectifier currents.
Overholser BR; Zheng X; Tisdale JE
J Cardiovasc Pharmacol; 2009 Sep; 54(3):253-62. PubMed ID: 19620881
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation associated with Jervell and Lange-Nielsen syndrome in a Japanese family.
Ohno S; Kubota T; Yoshida H; Tsuji K; Makiyama T; Yamada S; Kuga K; Yamaguchi I; Kita T; Horie M
Circ J; 2008 May; 72(5):687-93. PubMed ID: 18441444
[TBL] [Abstract][Full Text] [Related]
11. Novel compound heterozygous mutations T2C and 1149insT in the KCNQ1 gene cause Jervell and Lange-Nielsen syndrome.
Wang RR; Li N; Zhang YH; Wang LL; Teng SY; Pu JL
Int J Mol Med; 2011 Jul; 28(1):41-6. PubMed ID: 21380488
[TBL] [Abstract][Full Text] [Related]
12. Blockade of IKs by HMR 1556 increases the reverse rate-dependence of refractoriness prolongation by dofetilide in isolated rabbit ventricles.
So PP; Hu XD; Backx PH; Puglisi JL; Dorian P
Br J Pharmacol; 2006 Jun; 148(3):255-63. PubMed ID: 16565733
[TBL] [Abstract][Full Text] [Related]
13. Jervell and Lange-Nielsen syndrome: homozygous missense mutation of KCNQ1 in a Turkish family.
Bostan O; Temel ŞG; Cangül H; Archer CN; Çil E
Pediatr Cardiol; 2013; 34(8):2063-7. PubMed ID: 23400408
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness.
Oertli A; Rinné S; Moss R; Kääb S; Seemann G; Beckmann BM; Decher N
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498651
[No Abstract] [Full Text] [Related]
15. SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongation.
Kim M; Sager PT; Tester DJ; Pradhananga S; Hamrick SK; Srinivasan D; Das S; Ackerman MJ
Heart Rhythm; 2023 Apr; 20(4):589-595. PubMed ID: 36610526
[TBL] [Abstract][Full Text] [Related]
16. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
[TBL] [Abstract][Full Text] [Related]
17. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of acquired long QT syndrome in patients with propionic academia.
Bodi I; Grünert SC; Becker N; Stoelzle-Feix S; Spiekerkoetter U; Zehender M; Bugger H; Bode C; Odening KE
Heart Rhythm; 2016 Jun; 13(6):1335-45. PubMed ID: 26854997
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes.
Nalos L; Varkevisser R; Jonsson MK; Houtman MJ; Beekman JD; van der Nagel R; Thomsen MB; Duker G; Sartipy P; de Boer TP; Peschar M; Rook MB; van Veen TA; van der Heyden MA; Vos MA
Br J Pharmacol; 2012 Jan; 165(2):467-78. PubMed ID: 21718297
[TBL] [Abstract][Full Text] [Related]
20. Slow delayed rectifier potassium current blockade contributes importantly to drug-induced long QT syndrome.
Veerman CC; Verkerk AO; Blom MT; Klemens CA; Langendijk PN; van Ginneken AC; Wilders R; Tan HL
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):1002-9. PubMed ID: 23995305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
